Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' Hyperthyroidism
Stavros Stavrakis(Oklahoma City University), David C. Kem, Madeleine W. Cunningham(University of Oklahoma Health Sciences Center), Laura J. Chalmers(University of Oklahoma Health Sciences Center), Sean Hamlett(University of Oklahoma Health Sciences Center), Xichun Yu(University of Oklahoma Health Sciences Center), Ralph Lazzara(University of Oklahoma Health Sciences Center), Terry F. Davies(Icahn School of Medicine at Mount Sinai), Reji Pappy(University of Oklahoma Health Sciences Center), Eugene Patterson(University of Oklahoma Health Sciences Center), Shijun Huang(University of Oklahoma Health Sciences Center), Syed A. Morshed(Icahn School of Medicine at Mount Sinai)
Cited by 96
Related Papers
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Low-Level Transcutaneous Electrical Vagus Nerve Stimulation Suppresses Atrial Fibrillation
|Journal of the American College of Cardiology|2015|327
TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation)
|JACC. Clinical electrophysiology|2020|236
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
|JCI Insight|2016|226
Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2019|222